Contrary to some reports, taking statins, which are cholesterol-lowering drugs, offers no protection against Alzheimer's disease.
Ads by Google
Zetia reduces cholesterol 15 to 20 percent in most patients, no trial has been completed yet that has ever shown that it can reduce heart attacks and strokes.
Vytorin, a cholesterol medication by Merck,Schering-Plough is no more effective than a treatment available in generic form in the prevention of accumulation of plaque on artery walls.
A new study of cholesterol lowering prescription drugs Vytorin and Zetia concludes that Vytorin failed to slow the buildup of artery plaques more than a cheaper statin is certain to provoke questions among heart patients taking Vytorin or its sister drug Zetia.
The government is questioning if too many of the wrong people will take cholesterol-lowering Mevacor if it's sold without a prescription..
The average cholesterol level for U.S. adults last year decreased to 199.
People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke.
FDA to consider an application from Merck to market the 20-milligram dose of the anticholesterol medication Mevacor over the counter.
People are at an increased risk of memory problems and greater disability after stroke if they have low levels of 'good' cholesterol and high levels of homocysteine, an amino acid acquired mostly from eating meat.
PreMD's novel non-invasive skin cholesterol test has demonstrated the ability to detect risk of cardiovascular disease in asymptomatic subjects, according to new data being presented this morning at the Annual Scientific Sessions of the American Heart Association in Orlando, Florida.
Low-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism,
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life.
There is a significant disconnect between understanding what should be done to monitor and control high cholesterol and actually implementing recommended changes to lower cholesterol levels.
September is being observed as National Cholesterol Awareness Month
Abbott's single pill would target all three major blood lipids -- LDL-C "bad" cholesterol, HDL-C "good" cholesterol, and triglycerides.
Physicians often ignore or dismiss patient complaints about possible side effects of statins.
About 63% of U.S. women are concerned about high cholesterol, but only 32% know their cholesterol number.
'Good' cholesterol, renowned for its ability to protect against heart disease, can undergo detrimental changes in protein composition that make it 'bad' for the heart.
Adult women are more than twice as likely to know how much they weighed in high school as they are to know their current cholesterol number.
Older white men who are better able to cope with stress experience higher levels of so-called
With 40 percent of all heart attacks and related cardiovascular problems occurring in people who have low levels of so-called "good" cholesterol.
Researchers investigating cholesterol and lipid transport has performed experiments that cast serious doubt on the dominant hypothesis of how the body rids its cells of "bad" cholesterol (LDL) and increases "good" cholesterol (HDL).
Some patients were placed on cholesterol-lowering drugs before they'd made a good faith effort at improving their lifestyle to better their health. Some said they would have preferred starting with lifestyle alterations rather than cholesterol-lowering medication.
FDA has granted CLIA waived status to the Company's newest cholesterol test panel.
Colesevelam HCl can lower both A1C and LDL cholesterol levels in patients with type 2 diabetes mellitus who were uncontrolled on a metformin-based regimen.